Last year, generic drugmakers filed 150 complaints with the Food and Drug Administration that branded drug manufacturers were misusing the agency’s regulations to block them from offering cheaper alternatives for some useful but potentially dangerous drugs.
In the wake of those complaints, the FDA, with input from the Federal Trade Commission,
This content can only be accessed by FTC:WATCH subscribers.
FTC:WATCH is published 22 times a year - twice a month except in August when Northern Hemisphere governments leave town.FTC:WATCH is delivered in the following formats:
- online at ftcwatch.com via IP address recognition for enterprise wide distribution
- online at ftcwatch.com via secure username and password
- PDF version delivered by email
If you are an FTC:WATCH subscriber, please login to access this content: